APA aipamena

Chen, Y., Cai, H., Chen, W., Guan, Q., He, J., Guo, Z., & Li, J. (2020). A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy. Front Mol Biosci.

Chicago Style aipamena

Chen, Yanhua, Hao Cai, Wannan Chen, Qingzhou Guan, Jun He, Zheng Guo, and Jing Li. "A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy." Front Mol Biosci 2020.

MLA aipamena

Chen, Yanhua, et al. "A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy." Front Mol Biosci 2020.